Eric, I am so glad somebody finally said it. I had actually lost track of most of the "missed" events. Your piece is excellent and on point. I rarely ever post on here as I have found one is not allowed to in any way question the leadership at Cellceutix. While it may be good, it isn't perfect. So I just lurk. I think Mr. Earlich and Dr.Menon have done a good job, however some of the mistakes are amateur. Maybe momentous December is 2015? This fiasco with uplisting is unbelievable. The endless speculation on why, when and what is required is at times entertaining. Do people actually believe for a minute that it is a great vapor that somehow approves uplisting? Companies do it everyday. They go public, they list, they uplist. It isn't some great trip to see the wizard. When the uplist application was denied there should have been clear communication to the shareholders as to why it failed. They hired counsel to handle the process. The application by Mr. Earlich's own admission was on his desk for months and then somehow through some great unknown requirement that has yet to be defined it was missed. Was it closing price? Was it number of days above $3? 5 days above $4? bid price min? market cap? What criteria was applied and what was missed? It would seem a pretty clear cut and dry question and answer. And the plan to remedy the situation. If he doesn't know maybe he should ask the counsel that was hired to manage the process. I would suggest he go to the BOD and get some direction from their experience however as has already been touched on, it isn't there. The whole " I'll have to call NASDAQ" thing was bizarre. Oh the uplisting, I almost forgot??? Truth is we have actually down listed in the time I have been in this stock.
I am not really complaining, I am long the stock and at present up about %50 so what's not to like. Yes it could be better managed but it is a small OTC pink sheet biotech so these things are to be expected. There are going to be hiccups and delays. I think the company needs to work on it's transparency and communications.